Press Release | October 13, 2026
āshibio Presents Biomarker Data Supporting Vantictumab Development for ADO2 and a Prevalence Estimate of CLCN7-Related ADO2 of 1–4 per 20,000 Individuals
Read More
Press Release | October 9, 2026
TRexBio Announces Pricing of Initial Public Offering
Read More
Press Release | October 5, 2026
Introducing Fierce Biotech’s 2026 Fierce 15
Read More
Press Release | July 27, 2026
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
Read More
